# Nanox

Type: Company (NNOX)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/nanox
Canonical HTML page: https://gethealthbrief.com/entity/nanox

## Timeline

- **2026-09-09**: Q2 2026 results and business update announced — Nanox issues press release and files Form 6-K with SEC, disclosing commercialization progress, cost reduction, capital raise, and litigation disclosure.
- **2026-06-30**: Second quarter 2026 ended — Nanox's Q2 2026 reporting period closes, with financial statements later furnished to the SEC.
- **2026-06-12**: Class action complaint filed — Steele v. Nano-X Imaging Ltd et al filed in U.S. District Court of New Jersey, Case No. 1:26-cv-07062, alleging violations according to the press release.

## Recent coverage (1 stories)

### Nanox: 10 US Partners, First Philadelphia Scans, CMS Pathway Push
2026-09-10 01:21:51 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Health IT and imaging leaders should track Nanox's transition from device sales to reimbursed clinical scanning. The company announced ten U.S. distribution partners, initial patient scanning in Philadelphia, and a potential new CMS reimbursement pathway.
Full story: https://gethealthbrief.com/story/nanox-q2-2026-health-imaging-commercialization

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.